On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: Ally Financial (ALLY) upgraded at Evercore ISI... Amarin (AMRN) upgraded to Buy from Neutral at H.C. Wainwright... American Vanguard (AVD) upgraded to Buy from Hold at Topeka... Banc of California (BANC) upgraded to Outperform from Market Perform at Raymond James... CNOOC (CEO) upgraded to Buy from Underperform at BofA/Merrill... Five Below (FIVE) upgraded to Buy from Neutral at Dougherty... Fuel Systems (FSYS) upgraded to Buy from Hold at Lake Street... GNC Holdings (GNC) upgraded at Morgan Stanley... Horizon Technology (HRZN) upgraded to Buy from Hold at Wunderlich... Magnum Hunter (MHR) upgraded to Buy from Neutral at SunTrust... NCI Building (NCS) upgraded to Buy from Neutral at Citigroup... Shore Bancshares (SHBI) upgraded to Outperform from Neutral at Boenning & Scattergood... United Therapeutics (UTHR) upgraded at Argus... Verisk Analytics (VRSK) upgraded to Buy from Hold at Evercore ISI... Windstream (WIN) upgraded to Buy from Neutral at Citigroup... York Water (YORW) upgraded to Neutral from Underperform at Hilliard Lyons.
United Therapeutics upgraded at Argus As previously reported, Argus upgraded United Therapeutics to Buy from Neutral. The firm believes United Therapeutics is entering a new phase of growth following the recent approval of Unituxin in the treatment of neuroblastoma. Argus said the new product offers a diversified revenue stream and recommends buying shares. Price target is $195.